Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Future of You, a KQED Public Television segment, in “UC Riverside Professor Slams Feds, Stands by His Health App,” by Jon Brooks.
Following is an excerpt:
Enforcement actions like the one against UltimEyes are probably going to happen more frequently, says Bradley Merrill Thompson, a lawyer at Epstein, Becker & Green who works on regulatory issues with medical device and drug companies.
“The agreement is the next step in a whole series of cases the FTC has brought with respect to mobile applications,” he said. Last month, the FTC barred a company from making claims that the “Mole Detective” line of apps could detect melanoma.
“I fear that there will be a lot more cases,” Merrill Thompson said. “If you look at the mobile apps being promoted, it’s still the wild west out there. There’s still a lot of very small organizations operating out of their garage, making boastful claims about their technology.”
